Emerging drugs for the treatment of postsurgical pain

References

• Gan TJ, Habib AS, Miller TE, et al. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014;30(1):149–160.
   PubMed Web of Science ®Google Scholar
• Walker CT, Gullotti DM, Prendergast V, et al. Implementation of a standardized multimodal postoperative analgesia protocol improves pain control, reduces opioid consumption, and shortens length of hospital stay after posterior lumbar spinal fusion. Neurosurgery. 2020;87(1):130–136.
   PubMed Web of Science ®Google Scholar
• Iglesias SL, Rodríguez-Urmenyi C, Mangupli MM, et al. Continuous vs. intermittent intravenous analgesia for primary total knee replacement: analysis of the quality of the pain control, hospital stay and costs. Acta Ortop Mex. 2018;32(3):134–139.
   PubMedGoogle Scholar
• Ellis TA 2nd, Hammoud H, Dela Merced P, et al. Multimodal clinical pathway with adductor canal block decreases hospital length of stay, improves pain control, and reduces opioid consumption in total knee arthroplasty patients: a retrospective review. J Arthroplasty. 2018;33(8):2440–2448.
   PubMed Web of Science ®Google Scholar
• Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26(3):191–196.
   PubMed Web of Science ®Google Scholar
• Ayad S, Khanna AK, Iqbal SU, et al. Characterisation and monitoring of postoperative respiratory depression: current approaches and future considerations. Br J Anaesth. 2019;123(3):378–391.
   PubMed Web of Science ®Google Scholar
• DeWire SM, Yamashita DS, Rominger DH, et al. A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther. 2013;344(3):708–717.
   PubMed Web of Science ®Google Scholar
• Brummett CM, Waljee JF, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504.
   PubMed Web of Science ®Google Scholar
• Mattson CL, Tanz LJ, Quinn K, et al. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202–207.
   PubMed Web of Science ®Google Scholar
• Siuda ER, Carr R, Rominger DH, et al. Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics. Curr Opin Pharmacol. 2017;32:77–84.
   PubMed Web of Science ®Google Scholar
• HHS. Opioid crisis statistics. 2021 [cited 2021 Apr 25]. Available from: https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/index.html
   Google Scholar
• Trang T, Al-Hasani R, Salvemini D, et al. Pain and poppies: the good, the bad, and the ugly of opioid analgesics. J Neurosci. 2015;35(41):13879–13888.
   PubMed Web of Science ®Google Scholar
• Chu JJ, Janis JE, Skoracki R, et al. Opioid overprescribing and procedure-specific opioid consumption patterns for plastic and reconstructive surgery patients. Plast Reconstr Surg. 2021;147(4):669e–679e.
   PubMed Web of Science ®Google Scholar
• ElHawary H, Abdelhamid K, Meng F, et al. Erector spinae plane block decreases pain and opioid consumption in breast surgery: systematic review. Plast Reconstr Surg Glob Open. 2019;7(11):e2525.
   PubMedGoogle Scholar
• Chou R, Gordon DB, de Leon-casasola OA, et al., Management of postoperative pain: a clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J Pain. 17(2): 131–157. 2016.
   PubMed Web of Science ®Google Scholar
• Delaunay L, Catoire P. Oral opioids and postoperative pain management. Ann Fr Anesth Reanim. 2009;28(1):e27–32.
   PubMedGoogle Scholar
• Barker JC, DiBartola K, Wee C, et al. Preoperative multimodal analgesia decreases postanesthesia care unit narcotic use and pain scores in outpatient breast surgery. Plast Reconstr Surg. 2018;142(4):443e–450e.
   PubMed Web of Science ®Google Scholar
• Wheatley BM, Nappo KE, Christensen DL, et al. Effect of NSAIDs on bone healing rates: a meta-analysis. J Am Acad Orthop Surg. 2019;27(7):e330–e336.
   PubMed Web of Science ®Google Scholar
• Kandarian BS, Elkassabany NM, Tamboli M, et al., Updates on multimodal analgesia and regional anesthesia for total knee arthroplasty patients. Best Pract Res Clin Anaesthesiol. 33(1): 111–123. 2019.
   PubMed Web of Science ®Google Scholar
• Thybo KH, Hägi-Pedersen D, Dahl JB, et al. Effect of combination of paracetamol (acetaminophen) and ibuprofen vs either alone on patient-controlled morphine consumption in the first 24 hours after total hip arthroplasty: the PANSAID randomized clinical trial. JAMA. 2019;321(6):562–571.
   PubMed Web of Science ®Google Scholar
• Schwenk ES, Viscusi ER, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American society of regional anesthesia and pain medicine, the American Academy of pain medicine, and the American society of anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456–466.
   PubMed Web of Science ®Google Scholar
• Boenigk K, Echevarria GC, Nisimov E, et al. Low-dose ketamine infusion reduces postoperative hydromorphone requirements in opioid-tolerant patients following spinal fusion: a randomised controlled trial. Eur J Anaesthesiol. 2019;36(1):8–15.
   PubMed Web of Science ®Google Scholar
• Brinck EC, Tiippana E, Heesen M, et al. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2018;12(12):Cd012033.
   PubMed Web of Science ®Google Scholar
• ElHawary H, Joshi GP, Janis JE. Practical review of abdominal and breast regional analgesia for plastic surgeons: evidence and techniques. Plast Reconstr Surg Glob Open. 2020;8(12):e3224.
   PubMedGoogle Scholar
• Khansa I, Jefferson R, Khansa L, et al. Optimal pain control in abdominal wall reconstruction. Plast Reconstr Surg. 2018;142(3):142S–148S.
   PubMed Web of Science ®Google Scholar
• Walter CJ, Maxwell-Armstrong C, Pinkney TD, et al. A randomised controlled trial of the efficacy of ultrasound-guided transversus abdominis plane (TAP) block in laparoscopic colorectal surgery. Surg Endosc. 2013;27(7):2366–2372.
   PubMed Web of Science ®Google Scholar
• Elsharkawy H, El-Boghdadly K, Barrington M. Quadratus lumborum block: anatomical concepts, mechanisms, and techniques. Anesthesiology. 2019;130(2):322–335.
   PubMed Web of Science ®Google Scholar
• Ishio J, Komasawa N, Kido H, et al. Evaluation of ultrasound-guided posterior quadratus lumborum block for postoperative analgesia after laparoscopic gynecologic surgery. J Clin Anesth. 2017;41:1–4.
   PubMed Web of Science ®Google Scholar
• Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: a randomised controlled trial. Eur J Anaesthesiol| EJA. 2015;32(11):812–818.
   PubMed Web of Science ®Google Scholar
• Öksüz G, Bilal B, Gürkan Y, et al. Quadratus lumborum block versus transversus abdominis plane block in children undergoing low abdominal surgery: a randomized controlled trial. Reg Anesth Pain Med. 2017;42(5):674–679.
   PubMed Web of Science ®Google Scholar
• Chin KJ, El-Boghdadly K. Mechanisms of action of the erector spinae plane (ESP) block: a narrative review. Can J Anaesth. 2021;68(3):387–408.
   PubMed Web of Science ®Google Scholar
• Kot P, Rodriguez P, Granell M, et al. The erector spinae plane block: a narrative review. Korean J Anesthesiol. 2019;72(3):209.
   PubMed Web of Science ®Google Scholar
• Joshi GP, Janis JE, Haas EM, et al. Surgical site infiltration for abdominal surgery: a novel neuroanatomical-based approach. Plast Reconstr Surg Glob Open. 2016;4(12):e1181.
   PubMedGoogle Scholar
• Bujedo BM, Santos SG, Azpiazu AU. A review of epidural and intrathecal opioids used in the management of postoperative pain. J Opioid Manag. 2012;8(3):177–192.
   PubMedGoogle Scholar
• Sumida S, Lesley, BS MR, Hanna, MD MN, et al. Meta-analysis of the effect of extended-release epidural morphine versus intravenous patient-controlled analgesia on respiratory depression. J Opioid Manag. 2009;5(5):301–305.
   PubMedGoogle Scholar
• Research, P.M. Postoperative pain management market. 2018 [cited 2021 May 8]. Available from: https://www.persistencemarketresearch.com/market-research/postoperative-pain-management-market.asp
   Google Scholar
• Little A, Brower K, Keller D, et al. A cost-minimization analysis evaluating the use of liposomal bupivacaine in reconstructive plastic surgery procedures. Plast Reconstr Surg. 2019;143(4):1269–1274.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother. 2007;41(3):400–406.
   PubMed Web of Science ®Google Scholar
• Morita K, Motoyama N, Kitayama T, et al. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice. J Pharmacol Exp Ther. 2008;326(2):633–645.
   PubMed Web of Science ®Google Scholar
• Pang MH, Kim Y, Jung KW, et al. A series of case studies: practical methodology for identifying antinociceptive multi-target drugs. Drug Discov Today. 2012;17(9–10):425–434.
   PubMed Web of Science ®Google Scholar
• Ko SW, Vadakkan KI, Ao H, et al., Selective contribution of Egr1 (zif/268) to persistent inflammatory pain. J Pain. 6(1): 12–20. 2005.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004;41(3):171–174.
   PubMed Web of Science ®Google Scholar
• Azevedo Neto J, Costanzini A, De Giorgio R, et al. Biased versus partial agonism in the search for safer opioid analgesics. Molecules. 2020;25(17). DOI:https://doi.org/10.3390/molecules25173870
   Google Scholar
• Mori T, Takemura Y, Arima T, et al. Further investigation of the rapid-onset and short-duration action of the G protein-biased μ-ligand oliceridine. Biochem Biophys Res Commun. 2021;534:988–994.
   PubMed Web of Science ®Google Scholar
• Dahan A, van Dam CJ, Niesters M, et al., Benefit and risk evaluation of biased μ-receptor agonist oliceridine versus morphine. Anesthesiology. 133(3): 559–568. 2020.
   PubMed Web of Science ®Google Scholar
• Fishbane S, Jamal A, Munera C, et al. A phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med. 2020;382(3):222–232.
   PubMed Web of Science ®Google Scholar
• Gan T, Jones, JB, Schuller, R, et al. Analgesic and morphine-sparing effects of the peripherally-restricted kappa opioid agonist CR845 after intravenous administration in women undergoing a laparoscopic hysterectomy. in anesthesia and analgesia. Philadelphia (PA): Lippincott Williams & Wilkins; 2013.
   Google Scholar
• Lu L, Harnett M, Reines SA. IV tramadol: a novel option for US patients with acute pain-a review of its pharmacokinetics, abuse potential and clinical safety record. J Opioid Manag. 2020;16(4):297–306.
   PubMedGoogle Scholar
• Murphy DL, Lebin JA, Severtson SG, et al. Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics. Drug Saf. 2018;41(8):787–795.
   PubMed Web of Science ®Google Scholar
• Minkowitz H, Leiman D, Lu L, et al. IV tramadol–a new treatment option for management of post-operative pain in the US: an open-label, single-arm, safety trial including various types of surgery. J Pain Res. 2020;13:1155.
   PubMed Web of Science ®Google Scholar
• Singla NK, Pollak R, Gottlieb I, et al. Efficacy and safety of intravenously administered tramadol in patients with moderate to severe pain following bunionectomy: a randomized, double-blind, placebo-controlled, dose-finding study. Pain Ther. 2020;9(2):545–562.
   PubMed Web of Science ®Google Scholar
• Minkowitz H, Salazar H, Leiman D, et al. Intravenous tramadol is effective in the management of postoperative pain following abdominoplasty: a three-arm randomized placebo-and active-controlled trial. Drugs R D. 2020;20:225–236.
   PubMed Web of Science ®Google Scholar
• Chang TK, Huang C-W, Su W-C, et al. Extended-release dinalbuphine sebacate versus intravenous patient-controlled analgesia with fentanyl for postoperative moderate-to-severe pain: a randomized controlled trial. Pain Ther. 2020;9(2):671–681.
   PubMed Web of Science ®Google Scholar
• Lee SO, Huang LP, Wong CS. Preoperative administration of extended-release dinalbuphine sebacate compares with morphine for post-laparoscopic cholecystectomy pain management: a randomized study. J Pain Res. 2020;13:2247–2253.
   PubMed Web of Science ®Google Scholar
• Drugbank. Sufentail. 2021 [cited 2021 Apr 21]. Available from: https://go.drugbank.com/drugs/DB00708
   Google Scholar
• Pharmaceuticals, A. Sufentanil. 2021 [cited 2021 Oct 16]. Available from: https://www.acelrx.com/technology/sufentanil.html
   Google Scholar
• Noel E, Miglionico L, Leclercq M, et al. Sufentanil sublingual tablet system versus oral oxycodone for management of postoperative pain in enhanced recovery after surgery pathway for total knee arthroplasty: a randomized controlled study. J Exp Orthop. 2020;7(1):92.
   PubMedGoogle Scholar
• Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. 2010;11(8):1284–1293.
   PubMed Web of Science ®Google Scholar
• Southworth S, Peters J, Rock A, et al. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther. 2009;31(9):1922–1935.
   PubMed Web of Science ®Google Scholar
• Kroll PB, Meadows L, Rock A, et al. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen (i.v.-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. 2011;11(1):23–32.
   PubMed Web of Science ®Google Scholar
• Berkowitz RD, Mack RJ, McCallum SW. Meloxicam for intravenous use: review of its clinical efficacy and safety for management of postoperative pain. Pain Manag. 2021;11(3):249–258.
   PubMed Web of Science ®Google Scholar
• Singla N, McCallum SW, Mack RJ, et al. Safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate to severe pain following laparoscopic abdominal surgery. J Pain Res. 2018;11:1901–1903.
   PubMed Web of Science ®Google Scholar
• Rechberger T, Mack RJ, McCallum SW, et al. Analgesic efficacy and safety of intravenous meloxicam in subjects with moderate-to-severe pain after open abdominal hysterectomy: a phase 2 randomized clinical trial. Anesth Analg. 2019;128(6):1309–1318.
   PubMed Web of Science ®Google Scholar
• Christensen SE, Cooper SA, Mack RJ, et al. A randomized double-blind controlled trial of intravenous meloxicam in the treatment of pain following dental impaction surgery. J Clin Pharmacol. 2018;58(5):593–605.
   PubMed Web of Science ®Google Scholar
• Singla N, Bindewald M, Singla S, et al. Efficacy and safety of intravenous meloxicam in subjects with moderate-to-severe pain following abdominoplasty. Plast Reconstr Surg Glob Open. 2018;6(6):e1846.
   PubMedGoogle Scholar
• Bergese SD, Melson TI, Candiotti KA, et al. A phase 3, randomized, placebo-controlled evaluation of the safety of intravenous meloxicam following major surgery. Clin Pharmacol Drug Dev. 2019;8(8):1062–1072.
   PubMed Web of Science ®Google Scholar
• Oh J, Lee S, Kim A, et al. Safety, tolerability, and pharmacokinetic characteristics of a novel nonopioid analgesic, VVZ-149 injections in healthy volunteers: a first-in-class, first-in-human study. J Clin Pharmacol. 2018;58(1):64–73.
   PubMed Web of Science ®Google Scholar
• Song I, Cho S, Nedeljkovic SS, et al. Role of VVZ-149, a novel analgesic molecule, in the affective component of pain: results from an exploratory proof-of-concept study of postoperative pain following laparoscopic and robotic-laparoscopic gastrectomy. Pain Med. 2021;22(9):2037–2049.
   PubMed Web of Science ®Google Scholar
• Garrett WE, Kaeding CC, ElAttrache NS, et al. Novel drug OMS103HP reduces pain and improves joint motion and function for 90 days after arthroscopic meniscectomy. Arthroscopy. 2011;27(8):1060–1070.
   PubMed Web of Science ®Google Scholar
• Fanton GS, Dillingham MF, Wall MS, et al. Novel drug product to improve joint motion and function and reduce pain after arthroscopic anterior cruciate ligament reconstruction. Arthroscopy. 2008;24(6):625–636.
   PubMed Web of Science ®Google Scholar
• Omeros. Omeros announces publication of phase 2 clinical results for OMS103HP in arthroscopy: the journal of arthroscopic and related surgery. 2011 [cited 2021 Oct 27]. Available from: https://investor.omeros.com/news-releases/news-release-details/omeros-announces-publication-phase-2-clinical-results-oms103hp
   Google Scholar
• McDonnell A, Collins S, Ali Z, et al. Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy. Pain. 2018;159(8):1465–1476.
   PubMed Web of Science ®Google Scholar
• Pfizer. Efficacy of PF-05089771 in treating postoperative dental pain (NCT01529346). 2018 [cited 2018 Jun 1; 2021 Apr 21]. Available from: https://clinicaltrials.gov/show/NCT01529346
   Google Scholar
• Kushnarev M, Pirvulescu IP, Candido KD, et al. Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers. Expert Opin Investig Drugs. 2020;29(3):259–271.
   PubMed Web of Science ®Google Scholar
• Hemsen L, Cusack S, Minkowitz H, et al. A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery. J Pain Res. 2013;6:79–85.
   PubMed Web of Science ®Google Scholar
• Cusack SL, Jaros M, Kuss M, et al. Clinical evaluation of XaraColl®, a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studies. J Pain Res. 2012;5:217–225.
   PubMedGoogle Scholar
• Cusack SL, Kuss M, Jaros M, et al. A randomized, multicenter, pilot study comparing the efficacy and safety of a bupivacaine-collagen implant (XaraColl®) with the ON-Q PainBuster® post-op pain relief system following open gynecological surgery. J Pain Res. 2012;5:453–461.
   PubMedGoogle Scholar
• FDA. Xaracoll. 2021 [cited 2021 May 18]. Available from: https://search.usa.gov/search?query=xaracoll&affiliate=fda1
   Google Scholar
• Vyas KS, Rajendran S, Morrison SD, et al. Systematic review of liposomal bupivacaine (exparel) for postoperative analgesia. Plast Reconstr Surg. 2016;138(4):748e–756e.
   PubMed Web of Science ®Google Scholar
• Viscusi E, Gimbel JS, Pollack RA, et al. HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: phase III results from the randomized EPOCH 1 study. Reg Anesth Pain Med. 2019;44:700–706.
   Web of Science ®Google Scholar
• Ottoboni T, Gelder MS, O’Boyle E. Biochronomer technology and the development of APF530, a sustained release formulation of granisetron. J Exp Pharmacol. 2014;6:15–21.
   PubMedGoogle Scholar
• Viscusi E, Minkowitz H, Winkle P, et al. HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study. Hernia. 2019;23(6):1071–1080.
   PubMed Web of Science ®Google Scholar
• Lachiewicz PF, Lee G-C, Pollak RA, et al. HTX-011 reduced pain and opioid use after primary total knee arthroplasty: results of a randomized phase 2b trial. J Arthroplasty. 2020;35(10):2843–2851.
   PubMed Web of Science ®Google Scholar
• Goudra B, Singh N, Xue L, et al. Efficacy of new long-acting bupivacaine HTX-011 in providing pain relief for patients undergoing elective surgery - a meta-analysis of prospective randomized controlled trials. Anesth Essays Res. 2020;14(2):288–294.
   PubMedGoogle Scholar
• Pollak R, Cai D, Gan TJ. Opioid-free recovery from bunionectomy with HTX-011, a dual-acting local anesthetic combining bupivacaine and meloxicam, as the foundation of non-opioid multimodal analgesia. J Am Podiatr Med Assoc. 2021;111(3). DOI:https://doi.org/10.7547/20-204
   PubMed Web of Science ®Google Scholar
• Singla N, Winkle P, Bertoch T, et al. Opioid-free recovery after herniorrhaphy with HTX-011 as the foundation of a multimodal analgesic regimen. Surgery. 2020;168(5):915–920.
   PubMed Web of Science ®Google Scholar
• Blair HA. Bupivacaine/meloxicam prolonged release: a review in postoperative pain. Drugs. 2021;81(10):1203–1211.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Navarro AJ, Lagos N, Lagos M, et al. Neosaxitoxin as a local anesthetic: preliminary observations from a first human trial. J Am Soc Anesthesiologists. 2007;106(2):339–345.
   PubMedGoogle Scholar
• Wylie MC, Johnson VM, Carpino E, et al. Respiratory, neuromuscular, and cardiovascular effects of neosaxitoxin in isoflurane-anesthetized sheep. Reg Anesth Pain Med. 2012;37(2):152–158.
   PubMed Web of Science ®Google Scholar
• Epstein-Barash H, Shichor I, Kwon AH, et al. Prolonged duration local anesthesia with minimal toxicity. Proc Natl Acad Sci U S A. 2009;106(17):7125–7130.
   PubMed Web of Science ®Google Scholar
• Lobo K, Donado C, Cornelissen L, et al. A phase 1, dose-escalation, double-blind, block-randomized, controlled trial of safety and efficacy of neosaxitoxin alone and in combination with 0.2% bupivacaine, with and without epinephrine, for cutaneous anesthesia. Anesthesiology. 2015;123(4):873–885.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Tokumine J, Yorozu T, et al. Particulate-steroid betamethasone added to ropivacaine in interscalene brachial plexus block for arthroscopic rotator cuff repair improves postoperative analgesia. BMC Anesthesiol. 2016;16(1):84.
   PubMedGoogle Scholar
• Group, T.D. Pre-emptive scalp infiltration with diprospan plus ropivacaine for postoperative pain after craniotomy in adults. 2021 [cited 2021 Oct 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT04073069
   Google Scholar
• Shrestha N, Wu L, Wang X, et al. Preemptive infiltration with betamethasone and ropivacaine for postoperative pain in laminoplasty or laminectomy (PRE-EASE): study protocol for a randomized controlled trial. Trials. 2020;21(1):381.
   PubMed Web of Science ®Google Scholar
• Bertoch T, Brown CO, Wu C, et al. A phase 1/2, randomized, double-blind, comparator-controlled, dose-escalation study to evaluate the safety, pharmacokinetics, and efficacy of Tlc590 for postsurgical pain management following inguinal hernia repair, in ASA 2019. 2019.
   Google Scholar
• Kao HW, Lin -Y-Y, Gwathney WJ, et al. Formulation and evaluation of multilamellar vesicles ropivacaine in pain management. Int J Nanomedicine. 2019;14:7891–7901.
   PubMed Web of Science ®Google Scholar
• TLC. TLC announces topline results for TLC590 phase II trial for postsurgical pain management following bunionectomy. 2020 [cited 2021 Apr 21]. Available from: https://www.globenewswire.com/news-release/2020/05/31/2041231/0/en/TLC-Announces-Topline-Results-for-TLC590-Phase-II-Trial-for-Postsurgical-Pain-Management-following-Bunionectomy.html.
   Google Scholar
• Mont MA, Beaver WB, Dysart SH, et al. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty. 2018;33(1):90–96.
   PubMed Web of Science ®Google Scholar
• Balocco AL, Van Zundert PGE, Gan SS, et al., Extended release bupivacaine formulations for postoperative analgesia: an update. Curr Opin Anaesthesiol. 31(5): 636–642. 2018.
   PubMed Web of Science ®Google Scholar
• Pacira. Pacira announces FDA approval of supplemental new drug application for EXPAREL® (bupivacaine liposome injectable suspension) in pediatric patients. 2021 Mar 22. Available from: https://www.globenewswire.com/news-release/2021/03/22/2197275/0/en/Pacira-Announces-FDA-Approval-of-Supplemental-New-Drug-Application-for-EXPAREL-bupivacaine-liposome-injectable-suspension-in-Pediatric-Patients.html
   Google Scholar
• Hutchins J, Argenta P, Berg A, et al. Ultrasound-guided subcostal transversus abdominis plane block with liposomal bupivacaine compared to bupivacaine infiltration for patients undergoing robotic-assisted and laparoscopic hysterectomy: a prospective randomized study. J Pain Res. 2019;12:2087–2094.
   PubMed Web of Science ®Google Scholar
• Ilfeld BM, Eisenach JC, Gabriel RA. Clinical effectiveness of liposomal bupivacaine administered by infiltration or peripheral nerve block to treat postoperative pain: a narrative review. Anesthesiology. 2021;134(2):283–344.
   PubMedGoogle Scholar
• Hussain N, Brull R, Sheehy B, et al. Perineural liposomal bupivacaine is not superior to nonliposomal bupivacaine for peripheral nerve block analgesia: a systematic review and meta-analysis. Anesthesiology. 2021;134(2):147–164.
   PubMedGoogle Scholar
• Dasta J, Ramamoorthy S, Patou G, et al. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin. 2012;28(10):1609–1615.
   PubMed Web of Science ®Google Scholar
• Healio. FDA approves expanded use of long-acting local analgesic for children. 2021 [cited 2021 Oct 27]. Available from: https://www.healio.com/news/primary-care/20210323/fda-approves-expanded-use-of-longacting-local-analgesic-for-children
   Google Scholar
• Hadj A, Hadj A, Hadj A, et al. Safety and efficacy of extended-release bupivacaine local anaesthetic in open hernia repair: a randomized controlled trial. ANZ J Surg. 2012;82(4):251–257.
   PubMed Web of Science ®Google Scholar
• Newswire, P. DURECT announces top-line results from the PERSIST phase 3 trial of POSIMIR® (SABER®-Bupivacaine) did not meet primary efficacy endpoint. 2017 [cited 2021 Apr 21].
   Google Scholar
• Kivisto KT, Kallio A, Neuvonen PJ. Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. Eur J Clin Pharmacol. 1994;46(4):345–349.
   PubMed Web of Science ®Google Scholar
• Teikoku Pharma USA, I. Evaluating efficacy of the dexmedetomidine transdermal system for postoperative analgesia following abdominoplasty. 2020 [cited 2021 Oct 16]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04242407
   Google Scholar
• Hartrick CT, Pestano C, Carlson N, et al. Capsaicin instillation for postoperative pain following total knee arthroplasty: a preliminary report of a randomized, double-blind, parallel-group, placebo-controlled, multicentre trial. Clin Drug Investig. 2011;31(12):877–882.
   PubMed Web of Science ®Google Scholar
• Aasvang EK, Hansen JB, Malmstrøm J, et al. The effect of wound instillation of a novel purified capsaicin formulation on postherniotomy pain: a double-blind, randomized, placebo-controlled study. Anesth Analg. 2008;107(1):282–291.
   PubMed Web of Science ®Google Scholar
• Pharmaceuticals, A. ALGRX 4975. 2021 [cited 2021 Apr 21]. Available from: https://clinicaltrials.gov/ct2/results?recrs=&cond=&term=ALGRX+4975&cntry=&state=&city=&dist=
   Google Scholar
• Mamet J, Klukinov M, Yaksh TL, et al. Single intrathecal administration of the transcription factor decoy AYX1 prevents acute and chronic pain after incisional, inflammatory, or neuropathic injury. Pain. 2014;155(2):322–333.
   PubMed Web of Science ®Google Scholar
• Mamet J, Harris S, Klukinov M, et al. Pharmacology, pharmacokinetics, and metabolism of the DNA-decoy AYX1 for the prevention of acute and chronic post-surgical pain. Mol Pain. 2017;13:1744806917703112.
   Web of Science ®Google Scholar
• Adynxx. Adynxx reports positive results for phase 2b study of AYX1. 2015 Aug 11 [cited 2021 Apr 21]. Available from: https://www.google.com/search?q=Adynxx+Reports+Positive+Results+for+Phase+2b+Study+of+AYX1&rlz=1C5CHFA_enUS935US935&oq=Adynxx+Reports+Positive+Results+for+Phase+2b+Study+of+AYX1&aqs=chrome.69i57.414j0j4&sourceid=chrome¡UTF-8
   Google Scholar
• Analgesics, C. Novel TRPV1 agonist prodrugs for treating pain. 2021 [cited 2021 Apr 21]. Available from: https://www.concentricanalgesics.com/pipeline#:~:text=NOVEL%20TRPV1%20AGONIST%20PRODRUGS%20FOR%20TREATING%20PAIN&text=It%20is%20a%20first%2Din,to%20treat%20chronic%20pain%20conditions
   Google Scholar
• Analgesics, C. Concentric analgesics announces positive topline results from phase 2 clinical trial of CA-008 in bunionectomy. 2020 [cited 2021 Apr 21].
   Google Scholar
• Analgesics, C. Concentric analgesics announces additional positive results from phase 2 clinical trial of vocacapsaicin (CA-008) in total knee arthroplasty surgery. 2018 [cited 2021 Apr 21]. Available from: https://www.concentricanalgesics.com
   Google Scholar
• Beloeil H, Garot M, Lebuffe G, et al. Balanced opioid-free anesthesia with dexmedetomidine versus balanced anesthesia with remifentanil for major or intermediate noncardiac surgery. Anesthesiology. 2021;134(4):541–551.
   PubMed Web of Science ®Google Scholar
• HHS. HHS grant funding to address the U.S. opioid crisis. 2021 [cited 2021 Apr 25]. Available from: https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/opioids-grants-dashboard/index.html
   Google Scholar
• HHS. 5-point strategy to combat the opioid crisis. 2021 [cited 2021 Apr 25]. Available from: https://www.hhs.gov/opioids/about-the-epidemic/hhs-response/index.html
   Google Scholar